panitumumab
amgen
['panitumumab', 'colorectal', 'rectal']
we're excited for dr. alfonso de stefano's ( ) presentation on "intermittent or continuous panitumumab + folfiri for first-line treatment of patients with ras/braf wild type metastatic #colorectalcancer" at #wcgic2023 tomorrow! program: 
An online resource for intestinal cell researchers. Part of the @STEMCELLTech Science News service.